We're thrilled to announce the dates for SINOWAY 2026! -Apr.21~23,2026 CPhl Japan(Tokyo), booth No.:2D-34 -Jun.16~18,2026 CPhI Shanghai, booth No.:E1D57 -Oct.06~08,2026 CPhI Worldwide(Milano),booth No.: 10H67 We look forward to meeting you face-to-face at these events to discuss industry trends and ...

The three-day global pharmaceutical industry event -- CPHI Frankfurt 2025, has concluded successfully. SINOWAY's impressive presence at Booth 5.1B87 yielded fruitful results, and we extend our sincerest gratitude to all the clients, partners, and industry peers who visited our booth! Centered around...

From June 24-26, 2025, CPhI China kicked off grandly at SNIEC Shanghai. As a veteran exhibitor with over 20 years' participation, Sinoway's booth (E1D57b) attracted continuous crowds of global clients and partners. Our high-quality products sparked in-depth discussions, while the innovative enzymati...

The renowned global pharmaceutical event, CPhI Japan 2025, concluded successfully in Tokyo on April 11. Sinoway showcased its innovative capabilities and engaged in productive discussions with clients from Japan, South Korea, Southeast Asia, Europe, and South America, achieving remarkable results in...

‌Welcome to Sinoway Industry co., ltd. 's booth 6E31at CPhI Japan 2025!‌ We are thrilled to invite you to Sinoway's ‌Booth 6E31‌ to explore our cutting-edge solutions in ‌APIs‌, ‌pharmaceutical intermediates‌ and alongside our tailored ‌CDMO services‌‌. With over 30 years of expertise in global phar...

Peptides are unique pharmaceutical compounds that play vital roles in physiological processes, including hormones and neurotransmitters. Peptide drugs, known for their good druggability, high activity, low toxicity, and minimal drug interactions, generated global sales of $22 billion in 2015, making...

On April 5, 2024, a study from a Swedish university revealed a new class of antibiotics effective against multidrug-resistant bacteria, showing promise in treating bloodstream infections in mice. Published in *Proceedings of the National Academy of Sciences*, the discovery is significant due to the ...

In recent years, the pharmaceutical industry has witnessed a surge in interest and investment in antibody-drug conjugates (ADCs), a class of targeted therapies that combine the specificity of antibodies with the cytotoxic potency of drugs. This trend is evident in the increasing heat on ADC pipeline...